小児科
Placing pediatric patients and their families at the center.
From design to execution, we understand the inherent challenges of pediatric studies and will help you navigate the best path ahead.
Trusted guidance
Leverage our deep understanding of the diverse populations—spanning preterm infants to adolescents.
A patient-centric focus
Address the needs of pediatric patients and their families with our extensive regulatory, medical and operational expertise.
Efficient enrollment
Speed up your pediatric drug development plan with our best practices to efficiently enroll adolescents and young adult populations.
Minimizing patient and family burden
Participating in a pediatric trial requires a huge commitment not just from a patient, but also from their family. That's why our pediatric experts develop tailored solutions that address specific study considerations, minimize the burden of participation and support successful study conduct.
We share your passion to make a difference in patients' lives. Working with Fortrea, you'll get a partner that:
- 小児治験を細部にわたって理解しています
- Brings long-standing experience designing, planning and conducting pediatric programs
- 34 名の小児科医と、小児患者様と関わる経験を持つ 2,400 名以上の従業員からの総合的な知識を共有します。
Together, let’s overcome challenges and enable efficient delivery for pediatric studies.
Pediatric experience that matters
In the last 5 years, we have supported:
Our top therapeutic areas for pediatrics
Engaged team, committed to good work. We genuinely enjoy working with our Fortrea partners.
Large Pharma
インサイト
Get the latest updates from our pediatrics team
慢性腎臓病を患う小児患者様に対する腎臓保護薬としての SGLT2 阻害剤
Explore the benefits of SGLT2 inhibitors as renoprotective agents for pediatric patients. Fortrea's blog provides insights into diabetes medication and renal protection.
詳細はこちらから
Implementing a novel approach for recruiting a seasonal pediatric vaccine mega-trial
This case study demonstrates how Fortrea developed a novel approach to successfully delivery a large, industry-sponsored Phase III clinical trial to prevent hospitalization of infants due to a seasonal and dangerous illness.
ケーススタディをダウンロード
Conducting pediatric trials in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Conducting pediatric trials in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).
Download White Paper
Empowering young voices in pediatric clinical trials: Fortrea’s commitment to child rights and participation
Learn about the experiences of the young participants involved in the clinical trials.
詳細はこちらから
希少疾患デー：進歩を称え、未来へ希望を託す
Join Fortrea in celebrating Rare Disease Day, highlighting progress in medical research and hope for the future.
詳細はこちらからPediatric trials are complex and require the ability to adapt
As your agile partner, we work as an extension of your team and:
- 小児関連の規制対策を開発・実行し、PIP および iPSP をサポートするためのコンサルティングを提供します
- プロトコル作成を含む小児プログラムの開発および臨床研究デザインを提供します
- 実施可能性の見極めや実施に最適な国と施設の選定など、プログラムのカスタム戦略とプランニングを可能にします。
- Create relevant patient and family-facing materials including assent/consent for the different pediatric age groups
- Collaborate with relevant advocacy groups, such as the International Children’s Advisory Network (iCAN)